Ceftin (cefuroxime) for Lyme disease
July 1997
Glaxo is now promoting Ceftin (cefuroxime) for Lyme disease. It's the first antibiotic to be officially approved for this use.
It's for patients with symptoms of EARLY Lyme disease...usually a rash and flu-like symptoms. These symptoms usually show up BEFORE antibodies are detectable on blood tests.
Prompt treatment usually prevents long-term complications.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote